Nanobac Pharm (NNBP) Stock Chart & Stock Price History $0.0001 +0.00 (+∞) As of 08/15/2025 Add Compare Share Share Chart Stock AnalysisChartBuy This Stock Nanobac Pharm Stock Price Performance The Nanobac Pharm (NNBP) stock chart highlights key performance trends across multiple timeframes. As of the latest close, Nanobac Pharm traded at $0.00 with a market cap of and volume of 12,300 shares. Receive NNBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Nanobac Pharm and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00% NNBP Stock Chart for Friday, August, 22, 2025 NNBP Chart by TradingView Nanobac Pharm Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/21/2025$0.00$0.00$0.00$0.0012,300 shs$0.0008/20/2025$0.00$0.00$0.00$0.0012,300 shs$0.0008/19/2025$0.00$0.00$0.00$0.0012,300 shs$0.0008/18/2025$0.00$0.00$0.00$0.0012,300 shs$0.0008/15/2025N/A$0.00$0.00$0.0012,300 shs$0.00 Related Companies 180 Life Sciences Stock Chart 4D pharma Stock Chart 4Front Ventures Stock Chart Abattis Bioceuticals Stock Chart Abcam Stock Chart Acusphere Stock Chart Aeolus Pharmaceuticals Stock Chart Aesther Healthcare Acquisition Stock Chart Agentix Stock Chart Ainos Stock Chart Receive NNBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Nanobac Pharm and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:NNBP) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilver’s Still Under $35… For Now.Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...GoldenCrest Metals | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nanobac Pharm Please log in to your account or sign up in order to add this asset to your watchlist. Share Nanobac Pharm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access